Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 3Withdrawn 1Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Breast 1

Conditions

Solid Tumor 1Lung Neoplasms 1Heart Failure 1Breast Neoplasms 1Atrial Fibrillation 1

Interventions

Cyclophosphamide 1492Cisplatin 1414Paclitaxel 1317Radiotherapy 1261Carboplatin 1250Gemcitabine 1215Docetaxel 1109Bevacizumab 1030Fluorouracil 894Doxorubicin 792Dexamethasone 748Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 680Etoposide 678Irinotecan 634Filgrastim 621Cytarabine 586Leucovorin 579Nivolumab 558Vincristine 515Prednisone 475Cetuximab 465Bortezomib 459Erlotinib Hydrochloride 456Trastuzumab 447Methotrexate 438Lenalidomide 427Pemetrexed 420

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Interventional × Metoprolol × Clear all
NCT01585623 2025-03-05

Drug Interaction Study of SAR302503 in Patients With Solid Tumor

Bristol-Myers Squibb

Phase 1 Completed
16 enrolled
Other solid neoplasm

Solid Tumor

NCT01434134 2014-10-22

PRADA

University Hospital, Akershus

Phase 2 Completed
130 enrolled
Breast

Breast Neoplasms, Heart Failure

NCT01281787 2014-06-18

PRESAGE

European Institute of Oncology

Phase 3 Completed
320 enrolled
Thoracic

Atrial Fibrillation, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡